Quick Answer
Kraig Biocraft Laboratories, Inc. reported Common Stock Shares Outstanding of 773.63 million shares for the year ending 2016.
- Kraig Biocraft Laboratories, Inc. showed an increase of +9.3% in Common Stock Shares Outstanding from 2015 to 2016.
- This data is from Kraig Biocraft Laboratories, Inc.'s annual report (Form 10-K), filed with the SEC on March 22, 2017.
- XBRL data for this metric is available from 2013 to 2016 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: 664.20 million shares | Q3 2014: 673.96 million shares | Q1 2015: 676.90 million shares | Q2 2015: 681.58 million shares | Q3 2015: 694.81 million shares | Q1 2016: 719.11 million shares | Q2 2016: 755.30 million shares | Q3 2016: 767.95 million shares | Q4 2016: 773.63 million shares | Q1 2017: 780.96 million shares | Q2 2017: 787.45 million shares | Q3 2017: 802.20 million shares | Q4 2017: 816.85 million shares | Q1 2018: 816.85 million shares | Q2 2018: 816.88 million shares | Q3 2018: 816.88 million shares | Q4 2018: 816.88 million shares | Q1 2019: 835.73 million shares.
- Over the full 4 years of available data (2013 to 2016), Kraig Biocraft Laboratories, Inc.'s Common Stock Shares Outstanding has grown by 21.8%.
- Historical annual values: Fiscal year 2016: 773.63 million shares | Fiscal year 2015: 708.07 million shares | Fiscal year 2014: 673.97 million shares | Fiscal year 2013: 635.24 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: